The Global Scar Treatment Market size is expected to reach $39 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period.
A scar is the result of the body's natural process of repairing and replacing skin that has been injured or destroyed. Generally speaking, fibrous tissue is what makes up a scar. Scars may develop for a variety of causes, including infections, surgeries, traumas, or inflammation of the tissue. Inflammation of the tissue can also result in scar formation. Scars are able to be treated using topical remedies such as lotions and creams.
In addition, laser therapy, including CO2 laser and pulsed dye laser, is a viable option for the treatment of scars. The rise in the incidence of various kinds of scars, such as stretch marks, atrophic scars, hypertrophic scars, and keloid scars, is the primary factor fueling the expansion of the worldwide scar treatment market. A further factor that contributes to the expansion of the market is the rising prevalence of acne scars.
Scars may be treated with a variety of medications, including lotions, ointments, and gels, which can be purchased over the counter or with a doctor's prescription. Other scar treatments include laser surgery. If a person is being treated by a plastic surgeon and the scarring is the result of cosmetic or plastic surgery, then one should inquire with the physician about the possibility of purchasing therapy over-the-counter. If not, there are medications that may be prescribed to assist.
When treating scars that are very sensitive and itchy at the same time, steroids and some oral antihistamines are common therapy options. In a similar vein, see a dermatologist for guidance if there is scarring as a result of severe acne. When it comes to treating scars or providing preventative care, the medical professional may also suggest using pressure therapy or silicone gel sheeting.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
A scar is the result of the body's natural process of repairing and replacing skin that has been injured or destroyed. Generally speaking, fibrous tissue is what makes up a scar. Scars may develop for a variety of causes, including infections, surgeries, traumas, or inflammation of the tissue. Inflammation of the tissue can also result in scar formation. Scars are able to be treated using topical remedies such as lotions and creams.
In addition, laser therapy, including CO2 laser and pulsed dye laser, is a viable option for the treatment of scars. The rise in the incidence of various kinds of scars, such as stretch marks, atrophic scars, hypertrophic scars, and keloid scars, is the primary factor fueling the expansion of the worldwide scar treatment market. A further factor that contributes to the expansion of the market is the rising prevalence of acne scars.
Scars may be treated with a variety of medications, including lotions, ointments, and gels, which can be purchased over the counter or with a doctor's prescription. Other scar treatments include laser surgery. If a person is being treated by a plastic surgeon and the scarring is the result of cosmetic or plastic surgery, then one should inquire with the physician about the possibility of purchasing therapy over-the-counter. If not, there are medications that may be prescribed to assist.
When treating scars that are very sensitive and itchy at the same time, steroids and some oral antihistamines are common therapy options. In a similar vein, see a dermatologist for guidance if there is scarring as a result of severe acne. When it comes to treating scars or providing preventative care, the medical professional may also suggest using pressure therapy or silicone gel sheeting.
COVID-19 Impact Analysis
It is projected that the COVID-19 outbreak will have a negative influence on the development of the market for scar therapy, given that the majority of hospitals are now unable to treat outpatients as a result of the adoption of lockdowns in numerous countries. Patients who suffer from diabetes and vascular diseases are more vulnerable to the life-threatening effects of the COVID-19 virus. Because the treatment of scars is considered to be non-essential medical care, many scar treatments are either canceled or postponed in order to prevent the spread of the COVID-19 virus and to reduce the danger to patients.Market Growth Factors
A growing interest in pursuing careers in aviation and modeling
Some of the professions, like modeling and flying, are intricately connected to the outward attractiveness of people. Individuals who are interested in pursuing career opportunities in these sectors are expected to meet certain aesthetic criteria before being considered for employment. Candidates for the position of flight attendant are expected to meet certain requirements regarding their height, skin color, and body shape in order to be considered for the job. These requirements are outlined by the airline. The applications are often turned down if the potential employees have tattoos or scars that may be seen on their bodies.Impact of various social media platforms
The proliferation of social media platforms may be attributed to the widespread accessibility of mobile devices like smartphones, tablets, and computers, as well as the internet. Individuals may now communicate with people all over the globe thanks to the social media platforms like Instagram and YouTube, amongst others. In addition to this, the viewer's behavior is greatly influenced by social media in terms of adopting the most recent trends. It has been observed that it establishes beauty standards for both men and women, as well as for individuals of the third gender.Market Restraining Factors
Potential dangers and difficulties involved with the laser scar therapy
Laser resurfacing may be associated with certain unwanted side effects. When compared to ablative laser resurfacing, the side effects associated with nonablative methods are both milder and less likely to occur. Skin that has been treated may experience swelling, itching, or a burning feeling. The redness may be severe and may last for a few weeks or even months. Putting heavy lotions and bandages on your face after acne treatment may make your acne worse or lead you to develop a temporary case of small white lumps called milia on the area that was treated.End-use Outlook
Based on End-use, the scar treatment market is segmented into hospitals, clinics, retail pharmacies/e-commerce. In 2021, the retail pharmacies & e-commerce registered the prominent revenue share in the scar treatment market. This is because of the fast expansion of websites available online and the simple availability of scar treatment goods on these websites. OTC products are often purchased via online marketplaces like these, which do not need a prior consultation with a medical professional.Product Outlook
Based on products, the Scar Treatment Market is divided into injectables, topical products, and laser products, and others. In 2021, the laser products segment generated the significant revenue share in the market. Scars, particularly acne scars, may be less apparent after undergoing one of many different forms of laser or light therapy. Laser treatments make use of light with a specific wavelength in order to bring about the desired effect on the skin. The V beam is a pulsed dye laser operating at 595 nm (nanometers), and it is designed to target the skin's smaller blood veins.Topical Products Outlook
Based on topical products segment, the scar treatment market is further divided into creams, gels, silicon sheets, and others. Creams accounted for the highest revenue share in the scar treatment market in 2021. There is a wide variety of creams on the market that may help lighten dark spots on the skin, which are often brought on by pregnancy, birth control pills, hormone prescriptions, or an injury to the skin. These dark patches can be lightened. It does so by inhibiting the metabolic process in the skin that is responsible for discoloration.Scar Type Outlook
Based on Scar type, the scar treatment market is segmented into Atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. The atrophic scars had the most revenue share in 2021 in the scar treatment market. This is because acne scars are becoming more common in today's society. The majority of the time, scars like this are treated using topical creams and gels. Due to the high incidence of wound injuries among the general population, it is anticipated that the prevalence of keloid and hypertrophic scars will increase dramatically throughout the course of the projection period.Regional Outlook
Based on region, the scar treatment market is divided into North America, Europe, Asia Pacific, and LAMEA. The North American region held the largest revenue share in 2021. The rapid adoption of innovative items and the widespread high aesthetic awareness among the population are the primary drivers of market development in this area. In addition, sophisticated laser scar therapy equipment is seeing significant demand in the United States.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Strategies deployed in Scar Treatment Market
- Jun-2022: Cynosure introduced the PicoSure Pro device. The new device features a 755nm picosecond laser, provides energy in one trillionth of a second, and uses pressure to deliver treatments. Through this product launch, the company aims to fulfill the needs of medical professionals
- Mar-2022: Cynosure KK, part of Cynosure LLC partnered with Jeisys Medical KK. The distribution partnership agreement involves providing Jeisys exclusive distribution rights for Cynosure's key supreme products. Through this partnership, Cynosure further aims to provide patients and clients in Japan with creative solutions
- Sep-2021: Perrigo Company took over Héra SAS (HRA Pharma), a France-based developer of pharmaceutical medicines. The acquisition would expand Perrigo's market presence in European markets, and would also enhance its position as a market leader in the consumer self-care segment
- Jul-2021: Alma received FDA approval for its Alma Hybrid laser 1. The laser platform features a 10,600 nm (CO2) laser, and a 1570 nm laser meant for skin resurfacing. The Hybrid laser enables physicians to choose tailor-made treatment patterns by using a blend of wavelengths. Additionally, the laser product aims at reducing downtime for patients, at the same time improving the outcome of the treatment
- Mar-2021: Bausch Health Companies introduced Clear + Brilliant Touch laser. The new touch laser caters to patients of all ages and skin types and provides them with the benefits of two wavelengths, and further enables practitioners to provide patients with full treatment in a single appointment
- Jan-2019: Suneva Medical came into partnership with two companies, Healeon Medical and Puregraft. Healeon, a US-based provider of clinical expertise, medical devices, etc. Puregraft is a US-based manufacturer of biomaterial solutions. The partnership enhances Suneva's growth rate, and further, the new products expand and adds value to its product offerings
- Nov-2018: Alma Lasers acquired Nova Medical, an Israeli distributor of aesthetic technology-based devices. The acquisition would expand Alma's market reach, and would also set up a direct subsidiary in Israel. Additionally, the acquisition aims at preserving and keeping Alma's leading market position constant
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
By Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- Injectables
- Others
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Geography
North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Lumenis Be Ltd
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc
- Perrigo Company PLC
- Sientra, Inc
- Bausch Health Companies, Inc
- Alma Lasers (Sisram Medical Ltd.)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Scar Treatment Market, by End-use
1.4.2 Global Scar Treatment Market, by Product
1.4.3 Global Scar Treatment Market, by Scar Type
1.4.4 Global Scar Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Scar Treatment Market
Chapter 4. Global Scar Treatment Market by End-use
4.1 Global Hospitals Market by Region
4.2 Global Clinics Market by Region
4.3 Global Retail Pharmacies/ E-commerce Market by Region
Chapter 5. Global Scar Treatment Market by Product
5.1 Global Topical Products Market by Region
5.2 Global Scar Treatment Market by Topical Products Type
5.2.1 Global Creams Market by Region
5.2.2 Global Gels Market by Region
5.2.3 Global Silicon Sheets Market by Region
5.2.4 Global Others Market by Region
5.3 Global Laser Products Market by Region
5.4 Global Injectables Market by Region
5.5 Global Others Market by Region
Chapter 6. Global Scar Treatment Market by Scar Type
6.1 Global Atrophic Scars Market by Region
6.2 Global Hypertrophic & Keloid Scars Market by Region
6.3 Global Contracture Scars Market by Region
6.4 Global Stretch Marks Market by Region
Chapter 7. Global Scar Treatment Market by Region
7.1 North America Scar Treatment Market
7.1.1 North America Scar Treatment Market by End-use
7.1.1.1 North America Hospitals Market by Country
7.1.1.2 North America Clinics Market by Country
7.1.1.3 North America Retail Pharmacies/ E-commerce Market by Country
7.1.2 North America Scar Treatment Market by Product
7.1.2.1 North America Topical Products Market by Country
7.1.2.2 North America Scar Treatment Market by Topical Products Type
7.1.2.2.1 North America Creams Market by Country
7.1.2.2.2 North America Gels Market by Country
7.1.2.2.3 North America Silicon Sheets Market by Country
7.1.2.2.4 North America Others Market by Country
7.1.2.3 North America Laser Products Market by Country
7.1.2.4 North America Injectables Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Scar Treatment Market by Scar Type
7.1.3.1 North America Atrophic Scars Market by Country
7.1.3.2 North America Hypertrophic & Keloid Scars Market by Country
7.1.3.3 North America Contracture Scars Market by Country
7.1.3.4 North America Stretch Marks Market by Country
7.1.4 North America Scar Treatment Market by Country
7.1.4.1 US Scar Treatment Market
7.1.4.1.1 US Scar Treatment Market by End-use
7.1.4.1.2 US Scar Treatment Market by Product
7.1.4.1.3 US Scar Treatment Market by Scar Type
7.1.4.2 Canada Scar Treatment Market
7.1.4.2.1 Canada Scar Treatment Market by End-use
7.1.4.2.2 Canada Scar Treatment Market by Product
7.1.4.2.3 Canada Scar Treatment Market by Scar Type
7.1.4.3 Mexico Scar Treatment Market
7.1.4.3.1 Mexico Scar Treatment Market by End-use
7.1.4.3.2 Mexico Scar Treatment Market by Product
7.1.4.3.3 Mexico Scar Treatment Market by Scar Type
7.1.4.4 Rest of North America Scar Treatment Market
7.1.4.4.1 Rest of North America Scar Treatment Market by End-use
7.1.4.4.2 Rest of North America Scar Treatment Market by Product
7.1.4.4.3 Rest of North America Scar Treatment Market by Scar Type
7.2 Europe Scar Treatment Market
7.2.1 Europe Scar Treatment Market by End-use
7.2.1.1 Europe Hospitals Market by Country
7.2.1.2 Europe Clinics Market by Country
7.2.1.3 Europe Retail Pharmacies/ E-commerce Market by Country
7.2.2 Europe Scar Treatment Market by Product
7.2.2.1 Europe Topical Products Market by Country
7.2.2.2 Europe Scar Treatment Market by Topical Products Type
7.2.2.2.1 Europe Creams Market by Country
7.2.2.2.2 Europe Gels Market by Country
7.2.2.2.3 Europe Silicon Sheets Market by Country
7.2.2.2.4 Europe Others Market by Country
7.2.2.3 Europe Laser Products Market by Country
7.2.2.4 Europe Injectables Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Scar Treatment Market by Scar Type
7.2.3.1 Europe Atrophic Scars Market by Country
7.2.3.2 Europe Hypertrophic & Keloid Scars Market by Country
7.2.3.3 Europe Contracture Scars Market by Country
7.2.3.4 Europe Stretch Marks Market by Country
7.2.4 Europe Scar Treatment Market by Country
7.2.4.1 Germany Scar Treatment Market
7.2.4.1.1 Germany Scar Treatment Market by End-use
7.2.4.1.2 Germany Scar Treatment Market by Product
7.2.4.1.3 Germany Scar Treatment Market by Scar Type
7.2.4.2 UK Scar Treatment Market
7.2.4.2.1 UK Scar Treatment Market by End-use
7.2.4.2.2 UK Scar Treatment Market by Product
7.2.4.2.3 UK Scar Treatment Market by Scar Type
7.2.4.3 France Scar Treatment Market
7.2.4.3.1 France Scar Treatment Market by End-use
7.2.4.3.2 France Scar Treatment Market by Product
7.2.4.3.3 France Scar Treatment Market by Scar Type
7.2.4.4 Russia Scar Treatment Market
7.2.4.4.1 Russia Scar Treatment Market by End-use
7.2.4.4.2 Russia Scar Treatment Market by Product
7.2.4.4.3 Russia Scar Treatment Market by Scar Type
7.2.4.5 Spain Scar Treatment Market
7.2.4.5.1 Spain Scar Treatment Market by End-use
7.2.4.5.2 Spain Scar Treatment Market by Product
7.2.4.5.3 Spain Scar Treatment Market by Scar Type
7.2.4.6 Italy Scar Treatment Market
7.2.4.6.1 Italy Scar Treatment Market by End-use
7.2.4.6.2 Italy Scar Treatment Market by Product
7.2.4.6.3 Italy Scar Treatment Market by Scar Type
7.2.4.7 Rest of Europe Scar Treatment Market
7.2.4.7.1 Rest of Europe Scar Treatment Market by End-use
7.2.4.7.2 Rest of Europe Scar Treatment Market by Product
7.2.4.7.3 Rest of Europe Scar Treatment Market by Scar Type
7.3 Asia Pacific Scar Treatment Market
7.3.1 Asia Pacific Scar Treatment Market by End-use
7.3.1.1 Asia Pacific Hospitals Market by Country
7.3.1.2 Asia Pacific Clinics Market by Country
7.3.1.3 Asia Pacific Retail Pharmacies/ E-commerce Market by Country
7.3.2 Asia Pacific Scar Treatment Market by Product
7.3.2.1 Asia Pacific Topical Products Market by Country
7.3.2.2 Asia Pacific Scar Treatment Market by Topical Products Type
7.3.2.2.1 Asia Pacific Creams Market by Country
7.3.2.2.2 Asia Pacific Gels Market by Country
7.3.2.2.3 Asia Pacific Silicon Sheets Market by Country
7.3.2.2.4 Asia Pacific Others Market by Country
7.3.2.3 Asia Pacific Laser Products Market by Country
7.3.2.4 Asia Pacific Injectables Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Scar Treatment Market by Scar Type
7.3.3.1 Asia Pacific Atrophic Scars Market by Country
7.3.3.2 Asia Pacific Hypertrophic & Keloid Scars Market by Country
7.3.3.3 Asia Pacific Contracture Scars Market by Country
7.3.3.4 Asia Pacific Stretch Marks Market by Country
7.3.4 Asia Pacific Scar Treatment Market by Country
7.3.4.1 China Scar Treatment Market
7.3.4.1.1 China Scar Treatment Market by End-use
7.3.4.1.2 China Scar Treatment Market by Product
7.3.4.1.3 China Scar Treatment Market by Scar Type
7.3.4.2 Japan Scar Treatment Market
7.3.4.2.1 Japan Scar Treatment Market by End-use
7.3.4.2.2 Japan Scar Treatment Market by Product
7.3.4.2.3 Japan Scar Treatment Market by Scar Type
7.3.4.3 India Scar Treatment Market
7.3.4.3.1 India Scar Treatment Market by End-use
7.3.4.3.2 India Scar Treatment Market by Product
7.3.4.3.3 India Scar Treatment Market by Scar Type
7.3.4.4 South Korea Scar Treatment Market
7.3.4.4.1 South Korea Scar Treatment Market by End-use
7.3.4.4.2 South Korea Scar Treatment Market by Product
7.3.4.4.3 South Korea Scar Treatment Market by Scar Type
7.3.4.5 Singapore Scar Treatment Market
7.3.4.5.1 Singapore Scar Treatment Market by End-use
7.3.4.5.2 Singapore Scar Treatment Market by Product
7.3.4.5.3 Singapore Scar Treatment Market by Scar Type
7.3.4.6 Malaysia Scar Treatment Market
7.3.4.6.1 Malaysia Scar Treatment Market by End-use
7.3.4.6.2 Malaysia Scar Treatment Market by Product
7.3.4.6.3 Malaysia Scar Treatment Market by Scar Type
7.3.4.7 Rest of Asia Pacific Scar Treatment Market
7.3.4.7.1 Rest of Asia Pacific Scar Treatment Market by End-use
7.3.4.7.2 Rest of Asia Pacific Scar Treatment Market by Product
7.3.4.7.3 Rest of Asia Pacific Scar Treatment Market by Scar Type
7.4 LAMEA Scar Treatment Market
7.4.1 LAMEA Scar Treatment Market by End-use
7.4.1.1 LAMEA Hospitals Market by Country
7.4.1.2 LAMEA Clinics Market by Country
7.4.1.3 LAMEA Retail Pharmacies/ E-commerce Market by Country
7.4.2 LAMEA Scar Treatment Market by Product
7.4.2.1 LAMEA Topical Products Market by Country
7.4.2.2 LAMEA Scar Treatment Market by Topical Products Type
7.4.2.2.1 LAMEA Creams Market by Country
7.4.2.2.2 LAMEA Gels Market by Country
7.4.2.2.3 LAMEA Silicon Sheets Market by Country
7.4.2.2.4 LAMEA Others Market by Country
7.4.2.3 LAMEA Laser Products Market by Country
7.4.2.4 LAMEA Injectables Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Scar Treatment Market by Scar Type
7.4.3.1 LAMEA Atrophic Scars Market by Country
7.4.3.2 LAMEA Hypertrophic & Keloid Scars Market by Country
7.4.3.3 LAMEA Contracture Scars Market by Country
7.4.3.4 LAMEA Stretch Marks Market by Country
7.4.4 LAMEA Scar Treatment Market by Country
7.4.4.1 Brazil Scar Treatment Market
7.4.4.1.1 Brazil Scar Treatment Market by End-use
7.4.4.1.2 Brazil Scar Treatment Market by Product
7.4.4.1.3 Brazil Scar Treatment Market by Scar Type
7.4.4.2 Argentina Scar Treatment Market
7.4.4.2.1 Argentina Scar Treatment Market by End-use
7.4.4.2.2 Argentina Scar Treatment Market by Product
7.4.4.2.3 Argentina Scar Treatment Market by Scar Type
7.4.4.3 UAE Scar Treatment Market
7.4.4.3.1 UAE Scar Treatment Market by End-use
7.4.4.3.2 UAE Scar Treatment Market by Product
7.4.4.3.3 UAE Scar Treatment Market by Scar Type
7.4.4.4 Saudi Arabia Scar Treatment Market
7.4.4.4.1 Saudi Arabia Scar Treatment Market by End-use
7.4.4.4.2 Saudi Arabia Scar Treatment Market by Product
7.4.4.4.3 Saudi Arabia Scar Treatment Market by Scar Type
7.4.4.5 South Africa Scar Treatment Market
7.4.4.5.1 South Africa Scar Treatment Market by End-use
7.4.4.5.2 South Africa Scar Treatment Market by Product
7.4.4.5.3 South Africa Scar Treatment Market by Scar Type
7.4.4.6 Nigeria Scar Treatment Market
7.4.4.6.1 Nigeria Scar Treatment Market by End-use
7.4.4.6.2 Nigeria Scar Treatment Market by Product
7.4.4.6.3 Nigeria Scar Treatment Market by Scar Type
7.4.4.7 Rest of LAMEA Scar Treatment Market
7.4.4.7.1 Rest of LAMEA Scar Treatment Market by End-use
7.4.4.7.2 Rest of LAMEA Scar Treatment Market by Product
7.4.4.7.3 Rest of LAMEA Scar Treatment Market by Scar Type
Chapter 8. Company Profiles
8.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Line and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Acquisitions and Mergers:
8.2 Perrigo Company PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Bausch Health Companies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Sientra, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Molnlycke Health Care AB (Investor AB)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.6 Smith & Nephew PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional and Segmental Analysis
8.6.4 Research & Development Expense
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Suneva Medical, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Lumenis Be Ltd.
8.9.1 Company Overview
8.10. Merz Pharma GmbH & Co. KGaA
8.10.1 Company Overview
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc.
- Perrigo Company PLC
- Sientra, Inc.
- Bausch Health Companies, Inc.
- Alma Lasers (Sisram Medical Ltd.)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 258 |
| Published | January 2023 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 21307.7 Million |
| Forecasted Market Value ( USD | $ 38986.9 Million |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
